PHARMACOKINETIC-RESPONSE ANALYSIS OF FALDAPREVIR IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION WITH PRIOR RELAPSE

被引：2

作者：

Asselah, T. ^{[1
,2
]}

Zehnter, E. ^{[3
]}

Agarwal, K. ^{[4
]}

Sakai, Y. ^{[5
]}

Yatsuhashi, H. ^{[6
]}

Willems, B. ^{[7
]}

Wright, D. ^{[8
]}

Calinas, F. ^{[9
]}

Calleja, J. L. ^{[10
]}

Negro, F. ^{[11
]}

Stern, J. O. ^{[12
]}

Quinson, A. -M. ^{[12
]}

Sha, N. ^{[12
]}

Dorleacq, N. ^{[13
]}

Schobelock, M. ^{[12
]}

Jacobson, I. M. ^{[14
]}

机构：

[1] Univ Paris Diderot, Hop Beaujon, APHP, Clichy, France

[2] Hop Beaujon, INSERM, CRB 3, Clichy, France

[3] Schwerpunktpraxis Hepatol, Dortmund, Germany

[4] Kings Coll Hosp London, London, England

[5] Hyogo Coll Med Hosp, Kobe, Hyogo, Japan

[6] Nagasaki Med Ctr, Nagasaki, Japan

[7] Hop St Luc, CHUM, Montreal, PQ H2X 1P1, Canada

[8] Cent Texas Clin Res, Austin, TX USA

[9] Ctr Hosp Lisboa Cent, Lisbon, Portugal

[10] Univ Autonoma Madrid, Hosp Univ Puerta de Hierro Majadahonda, Madrid, Spain

[11] Univ Hosp, Geneva, Switzerland

[12] Boehringer Ingelheim Pharmaceut Inc, Ridgefield, CT 06877 USA

[13] Boehringer Ingelheim France SAS, Reims, France

[14] New York Presbyterian Weill Cornell Med Coll, New York, NY USA

来源：

JOURNAL OF HEPATOLOGY | 2014年 / 60卷 / 01期

关键词：

D O I：

10.1016/S0168-8278(14)61292-7

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

P1132

引用

页码：S458 / S459

页数：2

共 50 条

[1] PHARMACOKINETIC-RESPONSE ANALYSIS OF FALDAPREVIR IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: A POOLED ANALYSIS OF TWO PHASE III TRIALS
Foster, G. R.
Cooper, C.
Dieterich, D.
Ferenci, P.
Crespo, J.
Diago, M.
Dufour, J-F.
Lee, W. M.
Maevskaya, M.
Muellhaupt, B.
Wright, D.
Schuchmann, M.
Wright, M.
Bourliere, M.
Nishiguchi, S.
Abergel, A.
Streinu-Cercel, A.
Tanaka, Y.
Tomita, E.
Stern, J. O.
Scherer, J.
Olson, S.
Gallivan, J-P.
Jensen, D. M.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S454 - S455
[2] STARTVerso1: A randomized trial of faldaprevir plus pegylated interferon/ribavirin for chronic HCV genotype-1 infection
Ferenci, Peter
Asselah, Tarik
Foster, Graham R.
Zeuzem, Stefan
Sarrazin, Christoph
Moreno, Christophe
Ouzan, Denis
Maevskaya, Marina
Calinas, Filipe
Morano, Luis E.
Crespo, Javier
Dufour, Jean-Francois
Bourliere, Marc
Agarwal, Kosh
Forton, Daniel
Schuchmann, Marcus
Zehnter, Elmar
Nishiguchi, Shuhei
Omata, Masao
Kukolj, George
Datsenko, Yakov
Garcia, Miguel
Scherer, Joseph
Quinson, Anne-Marie
Stern, Jerry O.
JOURNAL OF HEPATOLOGY, 2015, 62 (06) : 1246 - 1255
[3] Faldaprevir and Deleobuvir for HCV Genotype 1 Infection
Zeuzem, Stefan
Soriano, Vincent
Asselah, Tarik
Bronowicki, Jean-Pierre
Lohse, Ansgar W.
Muellhaupt, Beat
Schuchmann, Marcus
Bourliere, Marc
Buti, Maria
Roberts, Stuart K.
Gane, Ed J.
Stern, Jerry O.
Vinisko, Richard
Kukolj, M. A. George
Gallivan, John-Paul
Boecher, Wulf-Otto
Mensa, Federico J.
NEW ENGLAND JOURNAL OF MEDICINE, 2013, 369 (07): : 630 - 639
[4] INTERFERON-STIMULATED GENE EXPRESSION IS ASSOCIATED WITH TREATMENT RESPONSE TO FALDAPREVIR PLUS PEGYLATED INTERFERON α-2a AND RIBAVIRIN IN PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION
Datsenko, Y.
Baum, P.
Schirmbeck, R.
Stern, J. O.
Sha, N.
Steinmann, G. G.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S309 - S310
[5] Interferon-Stimulated Gene Expression Is Associated With Treatment Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Patients With Chronic HCV Genotype-1 Infection
Datsenko, Yakov
Baum, Patrick
Schirmbeck, Reinhold
Stern, Jerry O.
Sha, Nanshi
Steinmann, Gerhard G.
GASTROENTEROLOGY, 2014, 146 (05) : S965 - S966
[6] Impact of Baseline Variables on Response to Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin in Patients With HIV/HCV Genotype-1
Tural, Cristina
Rockstroh, Juergen K.
Nelson, Mark
Bhagani, Sanjay
Ingiliz, Patrick
Soriano, Vicente
Nunez, Marina
Valantin, Marc-Antoine
Madruga, Jose Valdez R.
Rauch, Andri
Furtado, Juvencio
Battegay, Manuel
Stern, Jerry O.
Quinson, Anne-Marie
Boecher, Wulf
Vinisko, Richard
Manero, Montserrat
Dieterich, Douglas T.
GASTROENTEROLOGY, 2014, 146 (05) : S976 - S976
[7] VIROLOGICAL RESPONSE IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION RECEIVING FALDAPREVIR PLUS PEGYLATED INTERFERON α-2a AND RIBAVIRIN IS UNAFFECTED BY RIBAVIRIN DOSE REDUCTION
Asselah, T.
Jensen, D. M.
Foster, G. R.
Sulkowski, M. S.
Ouzan, D.
Morano, L.
Buynak, R.
Agarwal, K.
Hassanein, T.
Forton, D.
Cho, M.
Genne, D.
Kaita, K.
Maieron, A.
Preotescu, L.
Sarrazin, C.
Zehnter, E.
Streinu-Cercel, A.
Stern, J. O.
Datsenko, Y.
Drulak, M.
Voss, F.
Quinson, A. -M.
Ferenci, P.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S311 - S311
[8] NO EFFECT OF FALDAPREVIR ON RENAL FUNCTION IN TREATMENT-NAIVE PATIENTS WITH CHRONIC HCV GENOTYPE-1 INFECTION: POOLED DATA FROM TWO PHASE III TRIALS
Zeuzem, S.
Jensen, D. M.
Carvalho, A.
Diago, M.
Feinman, S. V.
Kowdley, K. V.
Kao, J. -H.
Maevskaya, M.
Negro, F.
Mantry, P.
Tanaka, Y.
Forton, D.
Genne, D.
Paik, S. W.
Zehnter, E.
Kuboki, M.
Lee, W. M.
Peng, C. -Y.
Yatsuhashi, H.
Stern, J. O.
Datsenko, Y.
Drulak, M.
Voss, F.
Boecher, W.
Ferenci, P.
JOURNAL OF HEPATOLOGY, 2014, 60 (01) : S451 - S451
[9] Virological Response in Treatment-Naive Patients With Chronic HCV Genotype-1 Infection Receiving Faldaprevir Plus Pegylated Interferon α-2A and Ribavirin Is Unaffected by Ribavirin Dose Reduction
Asselah, Tarik
Jensen, Donald M.
Foster, Graham
Sulkowski, Mark
Ouzan, Denis
Morano, Luis
Buynak, Robert
Agarwal, Kosh
Hassanein, Tarek
Forton, Daniel
Cho, Mong
Genne, Daniel
Kaita, Kelly
Maieron, Andreas
Preotescu, Liliana
Sarrazin, Christoph
Zehnter, Elmar
Streinu-Cercel, Adrian
Stern, Jerry O.
Datsenko, Yakov
Drulak, Murray
Voss, Florian
Quinson, Anne-Marie
Ferenci, Peter
GASTROENTEROLOGY, 2014, 146 (05) : S975 - S976
[10] Steatosis influences the relapse rate in chronic hepatitis C genotype-1 infection
Patel, K
Patton, HM
Vallee, M
Behling, C
Bylund, D
Pockros, PJ
McHutchison, JG
GASTROENTEROLOGY, 2003, 124 (04) : A782 - A783

← 1 2 3 4 5 →